Compass Health Analytics, Inc.

compass-inc.com

Compass Health Analytics delivers thorough and accurate analysis of health care costs and financial risk, regulatory issues, and key strategic decisions. Our services actuarial and economic analysis, strategic financial planning, data management and warehousing, all delivered with our experience and insight help our health care clients improve efficiency and access in the populations they serve.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMA TECH

EYENOVIA ANNOUNCES $15 MILLION CREDIT FACILITY WITH AVENUE VENTURE DEBT FUND

Eyenovia, Inc. | November 30, 2022

news image

Eyenovia, Inc. a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in combination with its own drug-device therapeutic programs for mydriasis, presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, announced that the company has entered into a $15 million credit facility with the Avenue Venture Opportunities Fund, L.P. The financing is intended to support manufacturing in anticipation of a MydCombi laun...

Read More

BUSINESS INSIGHTS

EYEPOINT PHARMACEUTICALS ANNOUNCED A DEBT REFINANCING WITH SILICON VALLEY BANK FOR $45 MILLION IN CREDIT FACILITIES

EyePoint Pharmaceuticals, Inc. | March 10, 2022

news image

A pharmaceutical company, EyePoint Pharmaceuticals, Inc.dedicated to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced that it has entered into a loan agreement with Silicon Valley Bank to replace its existing credit facility with CRG Servicing LLC for senior secured credit facilities for $45 million (CRG). A $30 million term loan facility and an asset-based revolving credit facility of up to $15 million will be used to replac...

Read More

CORONAVIRUS TRACKER: GSK, SANOFI BURNED BY WARP SPEED PICKS; EU MEMBERS LAUNCH COVID VAX ALLIANCE

Fiercepharma | June 04, 2020

news image

The Trump administration unveiled its finalists for Operation Warp Speed on Wednesday afternoon, with a notable Big Pharma bent. Meanwhile, Novavax—whose shot did not make the cut—recruited Japanese manufacturer AGC Biologics to churn out adjuvant for its coronavirus vaccine candidate. And on the heels of a controversial report by the Lancet, the New England Journal of Medicine published data showing hydroxychloroquine didn't do much to prevent infection in people exposed to the ...

Read More

PHARMA TECH

IKTOS ANNOUNCES DEPLOYMENT OF THEIR AI FOR DRUG DESIGN SOFTWARE MAKYA™ BY JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.

Iktos | December 09, 2021

news image

Iktos, a company specialized in Artificial Intelligence for new drug design today announced recent collaboration agreement in AI for new drug design with Jiangsu Hengrui Pharmaceuticals Co., Ltd., a leading global pharmaceutical company based in China with a focus on research, development, manufacturing, and commercialization of innovative and high-quality healthcare products. Under the agreement, Iktos’ de novo generative design software Makya™ will be used by Hengrui scientists to ...

Read More
news image

PHARMA TECH

EYENOVIA ANNOUNCES $15 MILLION CREDIT FACILITY WITH AVENUE VENTURE DEBT FUND

Eyenovia, Inc. | November 30, 2022

Eyenovia, Inc. a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in combination with its own drug-device therapeutic programs for mydriasis, presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, announced that the company has entered into a $15 million credit facility with the Avenue Venture Opportunities Fund, L.P. The financing is intended to support manufacturing in anticipation of a MydCombi laun...

Read More
news image

BUSINESS INSIGHTS

EYEPOINT PHARMACEUTICALS ANNOUNCED A DEBT REFINANCING WITH SILICON VALLEY BANK FOR $45 MILLION IN CREDIT FACILITIES

EyePoint Pharmaceuticals, Inc. | March 10, 2022

A pharmaceutical company, EyePoint Pharmaceuticals, Inc.dedicated to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced that it has entered into a loan agreement with Silicon Valley Bank to replace its existing credit facility with CRG Servicing LLC for senior secured credit facilities for $45 million (CRG). A $30 million term loan facility and an asset-based revolving credit facility of up to $15 million will be used to replac...

Read More
news image

CORONAVIRUS TRACKER: GSK, SANOFI BURNED BY WARP SPEED PICKS; EU MEMBERS LAUNCH COVID VAX ALLIANCE

Fiercepharma | June 04, 2020

The Trump administration unveiled its finalists for Operation Warp Speed on Wednesday afternoon, with a notable Big Pharma bent. Meanwhile, Novavax—whose shot did not make the cut—recruited Japanese manufacturer AGC Biologics to churn out adjuvant for its coronavirus vaccine candidate. And on the heels of a controversial report by the Lancet, the New England Journal of Medicine published data showing hydroxychloroquine didn't do much to prevent infection in people exposed to the ...

Read More
news image

PHARMA TECH

IKTOS ANNOUNCES DEPLOYMENT OF THEIR AI FOR DRUG DESIGN SOFTWARE MAKYA™ BY JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.

Iktos | December 09, 2021

Iktos, a company specialized in Artificial Intelligence for new drug design today announced recent collaboration agreement in AI for new drug design with Jiangsu Hengrui Pharmaceuticals Co., Ltd., a leading global pharmaceutical company based in China with a focus on research, development, manufacturing, and commercialization of innovative and high-quality healthcare products. Under the agreement, Iktos’ de novo generative design software Makya™ will be used by Hengrui scientists to ...

Read More